We describe 70 children with myelodysplastic syndrome (MDS) (refractory cytopenia (n = 31) and refractory anemia with excess blasts (n = 30) or blasts in transformation (n = 9)) who received umbilical cord blood (UCB) transplantation with a single UCB unit and a myeloablative conditioning regimen. Approximately 20% of children had secondary MDS. Median age at transplantation was 7 years and the median follow-up was 3 years. The day-60 probability of neutrophil recovery was 76%; recovery was faster after transplantation of matched or 1-locus mismatched UCB, irradiation-containing conditioning regimen, cell dose > 6 x 10(7)/kg and monosomy 7. Risks of treatment failure (recurrent disease or death) were lower in patients with monosomy 7 and transplantations after 2001. The 3-year disease-free survival (DFS) was 50% for transplantations after 2001 compared with 27% for the earlier period (P = 0.018). Transplantations after 2001 occurred within 6 months after diagnosis and used UCB units with higher cell dose. DFS was highest in patients with monosomy 7 (61%) compared with other karyotypes (30%), P = 0.017. These data suggest that transplantation of mismatched UCB graft is an acceptable alternative for children without a matched sibling or suitably matched unrelated adult donor. Leukemia (2011) 25, 449-454; doi:10.1038/leu.2010.285; published online 7 December 2010
Madureira, A. B. M., Eapen, M., Locatelli, F., Teira, P., Zhang, M., Davies, S. M., Picardi, A., Woolfrey, A., Chan, K., Socié, G., Vora, A., Bertrand, Y., Sales-Bonfim, C. M., Gluckman, E., Niemeyer, C., Rocha, V., Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation, <<LEUKEMIA>>, 2011; 25 (3): 449-454. [doi:10.1038/leu.2010.285] [https://hdl.handle.net/10807/249197]
Analysis of risk factors influencing outcome in children with myelodysplastic syndrome after unrelated cord blood transplantation
Locatelli, Franco;
2011
Abstract
We describe 70 children with myelodysplastic syndrome (MDS) (refractory cytopenia (n = 31) and refractory anemia with excess blasts (n = 30) or blasts in transformation (n = 9)) who received umbilical cord blood (UCB) transplantation with a single UCB unit and a myeloablative conditioning regimen. Approximately 20% of children had secondary MDS. Median age at transplantation was 7 years and the median follow-up was 3 years. The day-60 probability of neutrophil recovery was 76%; recovery was faster after transplantation of matched or 1-locus mismatched UCB, irradiation-containing conditioning regimen, cell dose > 6 x 10(7)/kg and monosomy 7. Risks of treatment failure (recurrent disease or death) were lower in patients with monosomy 7 and transplantations after 2001. The 3-year disease-free survival (DFS) was 50% for transplantations after 2001 compared with 27% for the earlier period (P = 0.018). Transplantations after 2001 occurred within 6 months after diagnosis and used UCB units with higher cell dose. DFS was highest in patients with monosomy 7 (61%) compared with other karyotypes (30%), P = 0.017. These data suggest that transplantation of mismatched UCB graft is an acceptable alternative for children without a matched sibling or suitably matched unrelated adult donor. Leukemia (2011) 25, 449-454; doi:10.1038/leu.2010.285; published online 7 December 2010I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.